Company intelligence / Profile preview

CSEM

Neuchâtel, Switzerlandcsem.com ↗

Ownership: Private
Employees: ~550
Development stage: Other

Overview

CSEM is a leading Swiss non-profit public-private innovation center specializing in the development of advanced microtechnologies, biosensors, organ-on-chip systems, digital health solutions, and lab automation tools. It collaborates with biotech/pharma companies to accelerate product development from concept through prototyping to small-scale manufacturing. Notably involved in projects like CLAMP for AI-driven prediction of lung cancer metastasis using genomics and organ-on-chip models.

Modalities: DeviceDiagnostic deviceBiosensorOrgan-on-chip system
Industry: Academic Hospital/University/Research

Partnerships

Adamant Innotech (bioassay/microfluidic chip validation)INVENesis (drug discovery screening tools)BMCC-funded CLAMP project partners for lung cancer metastasis prediction

Beyond the preview

Go deeper on CSEM.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CSEM.

Explore the full profile